Novo Nordisk Owner to Plow Obesity Drug Profit Into Green Market

📆 23/06/1402 01:29 ب.ظ
📰 BNNBloomberg

⏱ Reading Time:
26 sec. here
2 min. at publisher
📊 Quality Score:
News: 14%
Publisher: 50%

ایران اخبار اخبار

ایران آخرین اخبار,ایران سرفصلها

The shareholder that controls Novo Nordisk A/S is responding to a downturn in green assets by ratcheting up investments with profits from the obesity drugmaker.

Crypto Seeks Lifeline in Asia as US Crackdown Spurs More LayoffsCrypto Volatility Picks Up on Looming Sales From FTX’s $3.

4 Billion Token HoardETF Traders Are Pouring Cash Into EM’s Non-China Growth EnginesBitcoin ETFs With a $100 Billion Promise Put Old Funds in DangerCrypto Trading Volume Slumped to Lowest Level of the Year in AugustChina Is Being Left Out by a Record Number of New EM Stock FundsBreach of Microsoft Engineer’s Account Likely Led to Hack of US OfficialsSan Francisco Lost Its Chance to Be Blockchain Capital, Ripple’s Larsen SaysNvidia’s Rally Is Going to Show Traders What a Market Bubble Looks...

این خبر را خلاصه کرده ایم تا بتوانید سریع آن را بخوانید. اگر به خبر علاقه مند هستید، می توانید متن کامل را اینجا بخوانید. ادامه مطلب:

نوشتن نظر

ایران آخرین اخبار, ایران سرفصلها